Visiting Professorship on Breast Cancer
6 ESCO credits
11.10.2012 - 12.10.2012
Tirana, Albania
COURSES AND SEMINARS
Description
Visiting Professor: A. Eniu, RO
Host Chair: A. Sallaku, AL
General information
ORGANISING SECRETARIAT
Roberta Ventura
European School of Oncology
Via del Bollo, 4 - 20123 Milan, Italy
Email: rventura@eso.net
Tel: +39 028546 4532
VENUE
Centre of Telemedicine
Mather Teresa Hospital
Building Nr. 123
Rruga “Kongresi i Manastirit”
Tirana, Albania
OFFICIAL LANGUAGE
The official language of the event is English. No simultaneous translation will be provided.
SHARING PROGRESS IN CANCER CARE (SPCC)
Sharing Progress in Cancer Care programme (SPCC) is a pioneering partnership between the European School of Oncology (ESO) and some of the world’s leading pharmaceutical companies.
GlaxoSmithKline, sustaining member of the SPCC programme, has provided a grant towards ESO for this programme. GlaxoSmithKline has exercised no, and has no right to exercise any, editorial control over the programme, its content or speakers.
Faculty list
FACULTY
A. Eniu, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO
A. Sallaku, Mother Teresa Hospital, Tirana, AL
HEADS OF DEPARTMENTS
S. Celiku, Dept. of Gynecology, Mother Teresa Hospital, Tirana, AL
M. Ikonomi, Dept. of Pathology, Mother Teresa Hospital, Tirana, AL
A. Karaj, Dept. of Surgery, Mother Teresa Hospital, Tirana, AL
A. Sallaku, Dept. of Oncology and Radiotherapy, Mother Teresa Hospital, Tirana, AL
D. Tarifa, Dept. of Chemotherapy, Mother Teresa Hospital, Tirana, AL
Programme
11 October
12:30 | Welcome lunch |
13:30 | Approach to diagnosis and treatment |
15:00 | Discussion |
15:20 | Coffee break |
15:30 | Advances in the neoadjuvant treatment of HER2 positive and triple negative breast cancer: markers predictive for complete response A. Eniu, RO |
17:00 | Discussion |
18:1519:00 | Active participation to the live e-ESO session via internet: |
12 October
9:00 | Clinical cases presented by the Departments of the Mother Teresa Hospital |
11:00 | Clinical cases presented by A. Eniu |
12:00 | Discussion and closing remarks |